🇺🇸 FDA

Intelligence Platform

Patents

Browse 2,152 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7892738

Pot1 alternative splicing variants

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7892569

Methods of altering an immune response induced by CpG oligodeoxynucleotides

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7888116

Uses of notch receptors, notch ligands, and notch modulators in methods related to metabol

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7887818

Neospora caninum vaccine

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Feb 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7887812

Live attenuated Leishmania vaccines

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7884178

Griffithsin, glycosylation-resistant griffithsin, and related conjugates, compositions, nu

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7883710

Peptide vaccines against Group A streptococci

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7879810

Immunostimulatory nucleic acid molecules

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7875450

Virus-like particles for the induction of autoantibodies

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jan 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7875262

Aqueous starch-oil dispersions having improved UV stability and absorbing ability

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Jan 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7871986

Methods of stimulating an immune response against prostate specific antigen

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jan 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7871981

Inhibition of cell motility, angiogenesis, and metastasis

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jan 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7867977

Immunogenic peptides and methods of use for treating and preventing cancer

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jan 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7867974

Induction of tolerance by oral administration of factor VIII and treatment of hemophilia

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jan 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7867500

Cofactor that modulates steroid receptor activities

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jan 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7863262

Nitroxyl progenitors in the treatment of heart failure

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jan 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7862815

Methods for inhibiting angiogenesis with inhibitors of proadrenomedullin N-terminal 20 pep

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jan 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7855276

Framework residue substituted humanized COL-1 antibodies and their use

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Dec 21 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7855076

Use of discoidin domain receptor 1 (DDR1) and agents that affect the DDR1/collagen pathway

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Dec 21 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7851194

West Nile viruses with mutations in the 3′ terminal stem and loop secondary structure for

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Dec 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7846454

Cloned genomes of infectious hepatitis C viruses and uses thereof

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Dec 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7846455

Attenuated chimeric respiratory syncytial virus

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Dec 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7842729

Anti tubercular drug: compositions and methods

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Nov 30 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7842798

Production of attenuated, human-bovine chimeric respiratory syncytial virus vaccines

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 30 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted